Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland

INTRODUCTION: Currently, 15–20% of individuals with coronary artery disease (chronic coronary syndrome [CCS]) or peripheral artery disease (PAD) receiving routine treatment experience cardiovascular events (CVEs) within 3–4 years. Using PICOSTEPS (Patients-Intervention-Comparators-Outcomes-Setting-T...

詳細記述

保存先:
書誌詳細
出版年:Adv Ther
主要な著者: Soini, Erkki, Virtanen, Outi, Väätäinen, Saku, Briere, Jean-Baptiste, Bowrin, Kevin, Millier, Aurelie
フォーマット: Artigo
言語:Inglês
出版事項: Springer Healthcare 2020
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7467417/
https://ncbi.nlm.nih.gov/pubmed/32519113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01398-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料